Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke:implications in comorbidities of COPD by Arunachalam, Gnanapragasam et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emphysema is associated with increased inflammation in lungs
of atherosclerosis-prone mice by cigarette smoke
Citation for published version:
Arunachalam, G, Sundar, IK, Hwang, J, Yao, H & Rahman, I 2010, 'Emphysema is associated with
increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in
comorbidities of COPD' Journal of inflammation, vol. 7:34. DOI: 10.1186/1476-9255-7-34
Digital Object Identifier (DOI):
10.1186/1476-9255-7-34
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of inflammation
Publisher Rights Statement:
© 2010 Arunachalam et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
RESEARCH Open Access
Emphysema is associated with increased
inflammation in lungs of atherosclerosis-prone
mice by cigarette smoke: implications in
comorbidities of COPD
Gnanapragasam Arunachalam, Isaac K Sundar, Jae-woong Hwang, Hongwei Yao, Irfan Rahman*
Abstract
Background: Chronic obstructive pulmonary disease is associated with numerous vascular effects including
endothelial dysfunction, arterial stiffness and atherogenesis. It is also known that a decline in lung function is
associated with increased cardiovascular comorbidity in smokers. The mechanism of this cardiopulmonary dual risk
by cigarette smoke (CS) is not known. We studied the molecular mechanisms involved in development of
emphysema in atherosclerosis-prone apolipoprotein E-deficient (ApoE-/-) mice in response to CS exposure.
Methods: Adult male and female wild-type (WT) mice of genetic background C57BL/6J and ApoE-/- mice were
exposed to CS, and lung inflammatory responses, oxidative stress (lipid peroxidation products), mechanical
properties as well as airspace enlargement were assessed.
Results and Discussion: The lungs of ApoE-/- mice showed augmented inflammatory response and increased
oxidative stress with development of distal airspace enlargement which was accompanied with decline in lung
function. Interestingly, the levels and activities of matrix metalloproteinases (MMP-9 and MMP-12) were increased,
whereas the level of eNOS was decreased in lungs of CS-exposed ApoE-/- mice as compared to air-exposed ApoE-/-
mice or CS-exposed WT mice.
Conclusion: These findings suggest that CS causes premature emphysema and a decline of lung function in mice
susceptible to cardiovascular abnormalities via abnormal lung inflammation, increased oxidative stress and
alterations in levels of MMPs and eNOS.
Background
Chronic obstructive pulmonary disease (COPD) is char-
acterized by chronic airflow limitation resulting from
excessive airway inflammatory response mediated by
cigarette smoke (CS). Comorbidities such as cardiovascu-
lar disease, diabetes, lung cancer, and osteoporosis are
more prevalent in smokers and patients with COPD
[1-3]. Recent studies have shown that smokers with
altered forced expiratory volume in one second (FEV1)
and airflow limitation are associated with arterial stiff-
ness, exaggerated atherosclerosis and vice-versa [2,4,5].
Growing evidence also indicates that inflammation,
endothelial dysfunction and oxidative modification of
lipids play an important role in the pathogenesis of ather-
osclerosis and COPD [3,6,7]. In addition to CS, alcohol
consumption is also one among the important contribut-
ing factors involved in the pathogenesis of COPD and
atherosclerosis and their co-morbidities [8,9].
Apolipoprotein E-deficient (ApoE-/-) mice develop
atherosclerosis due to an accumulation of cholesterol
ester-enriched particles in the blood resulting from a
lack of triglyceride and cholesterol metabolism/lipid
transport [10]. These mice have a shorter life-span and
age faster than wild-type counterparts [11]. CS exposure
to ApoE-/- mice promotes arterial thrombosis and mod-
ulates the size and composition of neointimal lesions/
thickening [12], which is associated with increased
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oxidative stress, reduced glutathione levels and mito-
chondrial damage leading to atherosclerotic lesion for-
mation [6,13-17]. Massaro and Massaro have recently
shown that these mice have an impaired pulmonary
morphology and functional phenotype with a rapid
decline in lung function as they age [18]. However, the
underlying molecular mechanism of the pulmonary phe-
notype was not studied. We used the ApoE-/- mice,
which are prone to develop atherosclerosis [19,20], to
understand the molecular mechanism of pulmonary
phenotype in response to CS exposure, as well as to
study the concept of accelerated decline in lung function
and aging in cardiopulmonary comorbid conditions. We
determined the inflammatory response, oxidative stress
(lipid peroxidation products), levels/activities of matrix
metalloproteinases (MMP-9 and MMP-12) and NAD+-
dependent deacetylase sirtuin 1 (SIRT1) which is shown
to regulate endothelial nitric oxide synthase (eNOS)
activity (endothelial function) in lungs of ApoE-/- mice
exposed to CS.
Methods
Reagents
Unless otherwise stated, all biochemical reagents used in
this study were purchased from Sigma Chemicals Co.,
St. Louis, MO, USA. Antibodies used to detect proteins
include mouse specific SIRT1 and eNOS (Cell Signaling,
Danvers, MA), MMP-9 and MMP-12 (Santa Cruz Bio-
technology, Santa Cruz, CA) for western blotting and
immunoprecipitation.
Animals
Adult male and female wild-type (WT) mice of genetic
background C57BL/6J and ApoE-/- mice [19,20] (Strain
number, B6.129P2-Apoetm1Unc/J; stock number, 002052,
backcrossed to C57BL/6J for 10 generations, Jackson
Laboratory, Bar Harbor, ME) were housed in the inhala-
tion facility of the University of Rochester. These mice
were fed with regular standard Chow diet during hous-
ing and experimental procedures. ApoE-/- mice showed
obvious signs of atherosclerotic lesions in the aortic
sinus and ascending aorta after feeding with Chow diet
at 24 weeks of age with an early onset of signs seen
after approximately 3-4 months of age (Jackson Lab).
ApoE-/- mice develop atherosclerotic plaques at 2-3
months after feeding with a high-fat Western-type diet
[20]. All experimental protocols described in this study
were approved by the animal research committee of the
University of Rochester.
CS exposure
Adult mice (12 weeks old, body weight ranging from 30-
40 g, male and female) were exposed to CS for 3 days
using Baumgartner-Jaeger CSM2082i automated
cigarette smoking machine (CH Technologies, West-
wood, NJ) [21,22]. The smoke was generated from 3R4F
research cigarettes (University of Kentucky, Lexington,
KY). Mainstream CS was diluted with filtered air, and
directed into the exposure chamber. Monitoring of the
CS exposure (TPM per cubic meter of air, mg/m3) was
performed in real-time using MicroDust Pro-aerosol
monitor (Casella CEL, Bedford, UK) and verified daily
by gravimetric sampling. The smoke concentration was
set at a nominal value of approximately 300 mg/m3
TPM by adjusting the flow rate of the dilution air
[21,22]. The control mice were exposed to filtered air in
an identical manner.
Bronchoalveolar lavage and tissue harvest
The mice were intraperitoneally injected with 100 mg/kg
body weight of pentobarbiturate (Abbott laboratories,
Abbott Park, IL) and killed by exsanguination. The
lungs were lavaged three times with 0.6 ml of 0.9%
sodium chloride and removed en bloc. The bronchoal-
veolar lavage (BAL) fluid cell pellet was resuspended in
saline, and the total cell number was counted with a
hemocytometer. Differential cell count (500 cells/slide)
was performed on cytospin-prepared slides (Thermo
Shandon, Pittsburgh, PA) stained with Diff-Quik (Dade
Bering, Newark, DE).
Cytokine analysis
The levels of proinflammatory mediators such as mono-
cyte chemoattractant protein-1 (MCP-1) and chemokine
keratinocyte chemoattractant (KC) in lung homogenates
were measured by ELISA using respective duo-antibody
kits (R&D Systems, Minneapolis, MN) according to the
manufacturer’s instructions.
Immunohistochemical staining for tissue macrophages
Immunohistochemical staining for macrophages in lung
sections was performed as described previously [21,22].
The number of Mac-3-positive cells in each lung section
(5 random microscopic fields per lung section in 3 dif-
ferent sections) was counted manually at ×200 magnifi-
cation and averaged.
Lipid peroxidation products assay in lung homogenate
The right lung lobe was homogenized with ice-cold
20 mM Tris-HCl (pH 7.4) and centrifuged at 3,000 g at
4°C for 10 min, and the supernatants were collected.
Butylated hydroxytoluene (5 mM) was added to the
supernatant to prevent further peroxidation, and the
samples were immediately frozen in liquid nitrogen.
Lipid peroxidation products [malondialdehyde (MDA)
and 4-hydroxy-2-nonenal (4-HNE)] were measured
using a lipid peroxidation kit (Enzo Life Sciences, PA)
according to the manufacturer’s instructions [22].
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Measurement of lung mechanical properties
Lung mechanical properties were determined using
Scireq Flexivent apparatus (Scireq, Monteral, Canada).
The dynamic lung compliance and lung resistance were
measured in mice anesthetized by sodium pentobarbital
(50 mg/kg, intraperitoneally) and paralyzed with pancur-
onium (0.5 mg/kg, intraperitoneally). A tracheotomy
was performed and an 18-guage cannula was inserted 3
mm into an anterior nick in the exposed trachea and
connected to a computer controlled rodent ventilator.
Initially, the mice were ventilated with room air (150
breaths/min) at a volume of 10 ml/kg body mass. After
3 minutes of ventilation, measurement of lung mechani-
cal properties were initiated by the computer generated
program to measure dynamic lung compliance and
resistance. These measurements were repeated three
times for each animal.
Hematoxylin and Eosin (H&E) staining and mean linear
intercept analysis
Mouse lungs (which had not been lavaged) after CS expo-
sure were inflated by 1% low-melting agarose at a pressure
of 25 cm H2O, and then fixed with neutral buffered forma-
lin. Tissues were embedded in paraffin, sectioned (4 μm),
and stained with hematoxylin and eosin (H&E). The alveo-
lar size was estimated from the mean linear intercept (Lm)
of the airspace which is a measure of airspace enlarge-
ment/emphysema. Lm was calculated for each sample
based on 10 random fields observed at a magnification of
×200 using cross-lines as described previously [21,22].
Immunoblotting
Proteins (20 μg) from lung tissue homogenates were
used for immunoblotting as described previously
[21-24]. In brief, protein was electrophoresed on 7.5%
SDS-PAGE gel and transblotted on nitrocellulose mem-
brane (Amersham Biosciences, Piscataway, NJ). Mem-
branes were blocked with 5% (w/v) non-fat milk in PBS
containing 0.1% (v/v) Tween 20 and then incubated
with anti-SIRT1, anti-eNOS, anti-MMP-9 or anti-MMP-
12 antibodies. After washing, bound antibody was
detected using anti-rabbit/anti-mouse antibody linked to
horseradish peroxidase and bound complexes were
detected using enhanced chemiluminescence (Perkin
Elmer, Waltham, MA). Protein levels were measured by
BCA kit as per the manufacturer’s instructions using
BSA as standards (Thermo Scientific, Rockford, IL).
SIRT1 deacetylase activity assay
SIRT1 activity was assayed using a deacetylase colori-
metric activity assay kit according to the manufacturer’s
instructions (Biomol International, Plymouth Meeting,
PA). Briefly, SIRT1 was immunoprecipitated from whole
lung homogenates (100 μg protein). After the final
washing, Color de Lys substrate reagent and NAD+ were
added to the SIRT1 conjugated beads and incubated at
37°C for 80 min. The substrate-SIRT1 mixture was then
placed on a 96-well plate, and the Color de Lys developer
reagent was added to the wells at 37°C for 20 min. The
plate was then read at 405 nm using a spectrophotometer
(Model 680 microplate reader, Bio-Rad, Hercules, CA).
MMPs activity assay by zymography
The zymography was performed to determine the activ-
ity of MMPs in mouse lung as described previously [25].
Briefly, lung tissues were homogenized in 400 μl lysis
buffer (50 mM Tris-HCl, pH 7.4, with protease inhibi-
tors) on ice. One hundred micrograms of protein was
then mixed with equal volume sample buffer (80 mM
Tris-HCl, pH 6.8, 4% SDS, 10% glycerol, 0.01% bromo-
phenol blue) and then loaded on a 7.5% SDS-polyacryla-
mide gel containing 1 mg/ml gelatin which was overlaid
with 5% stacking gel. After electrophoresis, gels were
rinsed in distilled water, washed three times for 15 min-
utes each in 150 ml 2.5% Triton X-100 solution. Gels
were then incubated in 100-150 ml of 50 mM Tris-HCl
(pH 7.5), 10 mM CaCl2, 1 μM ZnCl2, 1% Triton X-100
and 0.02% NaN3. After incubation, gels were stained
with 100 ml Coomassie blue R-250 for 3 h and then
destained 1 h with destaining solution (50% methanol,
10% acetic acid). Gels were washed in distilled water for
20 minutes and then scanned. The intensity of bands
was quantified using image J software (Version 1.41,
National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
Data were presented as means ± SEM. Statistical analy-
sis of significance was calculated using one-way analysis
of variance followed by post hoc test for multigroup
comparisons using Stat View software. P < 0.05 was
considered as significant.
Results
ApoE-/- mice are susceptible to increased lung
inflammatory cell influx in response to CS
Augmented inflammatory response in the lung from envir-
onmental stress or toxicants results in the activation of
inflammatory cascades in microvasculature and vessel
walls leading to a potentiation of atherogenesis
[12,13,26,27]. Atherogenic prone ApoE
-/- were exposed to
CS for 3 days, and the number of neutrophils and macro-
phages in BAL fluid as well as in the lungs were deter-
mined. CS exposure led to a higher number of neutrophil
influx in BAL fluid of ApoE-/- mice as compared to WT
mice (Fig. 1A). However, CS exposure significantly
decreased the number of macrophages in BAL fluid of
ApoE-/- mice, but not in WT mice (Fig. 1B). Interestingly,
the macrophage infiltration in lung interstitium of
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air-exposed ApoE-/- mice was significantly increased as
compared to air- and CS-exposed WT mice. This was aug-
mented in CS-exposed ApoE-/- mice (Fig. 1C, D).
CS exposure augments the proinflammatory cytokine
levels in lungs of ApoE-/- mice
In order to confirm whether the inflammatory cell influx
was associated with proinflammatory cytokine release in
ApoE-/- mice, the levels of proinflammatory mediators,
such as MCP-1 and KC, which can recruit macrophages
and neutrophils in the lung, were measured in lung
homogenates of air- and CS-exposed WT and ApoE-/-
mice. CS-exposure to ApoE-/- mice significantly
increased the levels of MCP-1 and KC as compared to
CS-exposed WT mice (Fig. 2A, B). These results suggest
that increased levels of MCP-1 and KC may contribute
to enhanced macrophage and neutrophil influx in the
lungs of ApoE-/- mice after CS exposure.
ApoE-/- mice lung shows increased oxidative stress as
lipid peroxidation products (4-HNE and MDA) in response
to CS
We previously showed that CS-induced oxidative stress
is involved in the development of emphysema and
Figure 1 Neutrophil and macrophage influx into BAL fluid and lungs of ApoE-/- mice exposed to CS. Neutrophil and macrophage influx
were analyzed in BAL fluid by Diff-Quik staining on cytospin slides (A and B respectively). Data are shown as mean ± SEM (n = 3-4 mice per
group). *P < 0.05, ***P < 0.001, significant compared with corresponding air-exposed mice. +P < 0.05, significant compared with CS-exposed WT
mice. Lung sections of air- and CS-exposed WT and ApoE-/- mice were stained with anti-mouse Mac-3 antibody (C). Mac-3-positive cells (dark
brown) were identified by immunohistochemical staining (indicated by arrows and insets), Original magnification: ×200. Histogram (D) represents
mean ± SEM. **P < 0.01, significant compared with corresponding air-exposed mice. ++P < 0.01, significant compared with CS-exposed WT mice.
##P < 0.01, significant compared with air-exposed WT mice (n = 4).
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vascular endothelial dysfunction [21,22,28]. Therefore,
we assessed the lung levels of lipid peroxidation pro-
ducts (4-HNE and MDA) as a measure of increased oxi-
dative stress in WT and ApoE-/- mice exposed to CS. A
significant increase in 4-HNE and MDA levels were
observed in CS-exposed ApoE-/- mice lung compared to
WT (Fig. 3). This result suggests that CS-induced oxida-
tive stress and lipid peroxidation might be the causative
factor for an increased inflammatory response, which
would lead to the development of premature emphy-
sema and vascular abnormalities in these mice.
ApoE-/- mice show increased airspace enlargement and
alterations in lung mechanical properties in response to
CS exposure
We measured the airspace enlargement and decline in
lung function, which are the characteristics of pulmon-
ary emphysema/COPD, in WT and ApoE-/- mice
exposed to air or CS. ApoE-/- mice exposed to CS
showed a significant increase in alveolar size as com-
pared to air- and CS-exposed WT mice (Fig. 4A, B).
There was also a spontaneous airspace enlargement
seen in ApoE-/- mice. The lung compliance (measured
as lung function) was significantly increased in air- and
CS-exposed ApoE-/- mice compared to air- and CS-
exposed WT mice (Fig. 4C, D). The lung resistance was
significantly lowered in air- and CS-exposed ApoE-/-
mice compared to air- and CS-exposed WT mice. These
data suggest that lungs of ApoE-/- mice have impaired
alveologenesis and alveolar destruction with altered lung
mechanical properties, which were augmented by acute
CS exposure.
ApoE-/- mice show increased levels and activities of
matrix metalloproteinases, and reduction of SIRT1 levels
and activity as well as eNOS levels in lungs by CS
MMPs, particularly increased levels of MMP-9 and
MMP-12, are involved in CS-mediated airspace enlarge-
ment/alveolar wall destruction (emphysema). Hence, we
determined whether the levels and activities of MMP-9
and MMP-12 were altered in ApoE-/- mice after CS
exposure. The levels of MMP-9 and MMP-12 were sig-
nificantly increased in lungs of CS-exposed ApoE-/-
mice compared to that of WT mice (Fig. 5A-C). Simi-
larly, there was a 1.8 and 2.2-fold increase in MMP-9
and MMP-12 activities respectively in lungs of WT mice
exposed to CS as compared to air-exposed WT mice.
Air-exposed ApoE-/-mice showed a 1.6 and 1.8-fold
increase in corresponding MMP-9 and MMP-12 activ-
ities in the lungs as compared to air-exposed WT mice,
which was further augmented in CS-exposed ApoE-/-
mice (2.8-fold increase in MMP-9 activity and 2.6-fold
increase in MMP-12 activity).
We determined the levels of SIRT1 and eNOS in
lungs of ApoE-/- mice exposed to CS. The basal endo-
genous abundances of SIRT1 and eNOS were signifi-
cantly decreased in ApoE-/- mice compared with WT
mice (Fig. 6A-D). ApoE-/- mice exposed to CS showed
further reduction in SIRT1 level and activity (Fig. 6E)
and eNOS levels (Fig. 6B, D) compared to air- and CS-
exposed WT mice. Hence, CS-mediated reduction in
SIRT1 and eNOS levels was associated with pulmonary
Figure 2 Levels of pro-inflammatory mediators in lungs of
ApoE-/- mice exposed to CS. The levels of pro-inflammatory
mediators such as MCP-1 (A) and KC (B) were measured by ELISA in
lung homogenates of air- and CS-exposed WT and ApoE-/- mice.
Data are shown as mean ± SEM (n = 3-4 mice per group). **P <
0.01, ***P < 0.001, significant compared with corresponding air-
exposed mice. +P < 0.05, ++P < 0.01 significant compared with CS-
exposed WT mice. #P < 0.05, significant compared with air-exposed
WT mice
Figure 3 Levels of lipid peroxidation products (4-HNE and
MDA) in lungs of ApoE-/- mice exposed to CS. Levels of 4-HNE
and MDA were measured spectrophotometrically in lung
homogenates of WT and ApoE-/- mice exposed to CS. Histograms
represent mean ± SEM of n = 3-4 per group. ***P < 0.001,
significant compared with corresponding air-exposed mice. +++P <
0.001, significant compared with CS-exposed WT mice. ###P < 0.001,
significant compared with air-exposed WT mice.
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functional and morphological phenotype alterations in
ApoE-/- mice.
Discussion
Prolonged exposure to CS leads to the development of
COPD associated with arterial stiffness, endothelial dys-
function and atherosclerosis-mediated cardiovascular
diseases [1-5]. The lungs of ApoE-/- mice also have
impaired alveologenesis with altered lung mechanical
properties [18]. However, the underlying molecular
mechanism of this pulmonary phenotype in ApoE-/- by
CS is not known. We used ApoE-/- mice to study the
pulmonary phenotype in response to CS. We found that
the air-exposed WT and ApoE-/- mice showed no
change in neutrophil influx, whereas CS-exposed
ApoE-/- mice had an increased neutrophil influx in BAL
fluid compared to CS-exposed WT mice. The macro-
phage influx in lung interstitium was also significantly
increased in lungs of CS-exposed ApoE-/- mice com-
pared to CS-exposed WT or control ApoE-/- mice.
MCP-1 and KC (pro-inflammatory cytokines) are cap-
able of recruiting macrophages and neutrophils
Figure 4 Airspace enlargement and lung mechanical properties in ApoE-/- mice exposed to CS. Representative figure of H&E stained lung
sections from air- and CS-exposed WT and ApoE-/- mice (A). Arrows indicate alveolar enlargement. Mean linear intercept (Lm) was calculated in
H&E stained lung sections. Original magnification: ×200. Histogram represents (B) mean ± SEM (n = 3-4 mice per group). **P < 0.01, significant
compared with corresponding air-exposed mice. ++P < 0.01, significant compared with CS-exposed WT mice. ##P < 0.01, significant compared
with air-exposed WT mice. Lung compliance (C) and resistance (D) were measured in air- and CS-exposed WT and ApoE-/- mice using Flexivent.
Data are shown as mean ± SEM (n = 3-4 mice per group). **P < 0.01, significant compared with corresponding air-exposed mice. +++P < 0.001,
significant compared with CS-exposed WT mice. #P < 0.05, ###P < 0.001, significant compared with air-exposed WT mice.
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respectively into the lungs in the presence and absence
of inflammatory stimuli [29,30]. The susceptibility of
ApoE-/- mice to CS-mediated increased inflammation
was further confirmed by the increased levels of proin-
flammatory cytokine (MCP-1 and KC) release in lungs
of adult 12 weeks old ApoE-/- mice exposed to CS for
acute period (3 days) when fed the regular/standard
Chow-diet. Interestingly, air-exposed ApoE-/- mice also
showed increased pro-inflammatory cytokine release
possibly due to infiltrated macrophages in the lung,
which was further increased in response to CS exposure.
Previously, it has been shown that lungs of ApoE-/- mice
Figure 5 Levels of MMPs in lungs of ApoE-/- mice exposed to CS. The levels of MMP-9 and MMP-12 were determined in lungs of air- and
CS-exposed WT and ApoE-/- mice by immunoblotting (A). Histograms (B and C) represent mean ± SEM (n = 3-4 per group). **P < 0.01, ***P <
0.001, significant compared with corresponding air-exposed mice. +P < 0.05, ++P < 0.01, significant compared with CS-exposed WT mice. #P <
0.05, significant compared with air-exposed WT mice.
Figure 6 SIRT1 levels and activity, and eNOS level in lungs of ApoE-/- mice exposed to CS. SIRT1 and eNOS levels were measured in lungs
of WT and ApoE-/- mice exposed to CS (A and B). Histograms (C and D) represent mean ± SEM of relative levels of SIRT1 and eNOS respectively
(n = 3-4 per group). SIRT1 deacetylase activity was measured in lungs of WT and ApoE-/- mice exposed to CS (E). *P < 0.05, **P < 0.01, ***P <
0.001 significant compared with respective air-exposed mice. +P < 0.05, ++P < 0.01, significant compared with CS-exposed WT mice. #P < 0.05,
##P < 0.01, ###P < 0.001, significant compared with air-exposed WT mice.
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had increased levels of pro-inflammatory cytokine (TNF-
a, IL-1) and expression of adhesion molecules, such as
inter-cellular adhesion molecule-1 (ICAM-1) and vascu-
lar cell adhesion molecule-1 (VCAM-1) [31]. These find-
ings suggest that ApoE-/- mice are prone to develop
atherosclerotic lesions by activation of proatherogenic
molecules which are associated with augmented lung
inflammatory response. However, it is not known
whether T and B cells are involved in the inflammatory
response seen in ApoE-/- mice, since these cells also
play an important role in the development of emphy-
sema/COPD in humans. Further studies are required to
confirm this possibility.
CS either directly or indirectly induces the production
of ROS such as superoxide anions, hydroxyl radicals and
hydrogen peroxide. We have previously shown that the
imbalance between oxidants and antioxidants are asso-
ciated with lung inflammatory response and develop-
ment of emphysema [21,22]. In the present study, CS
exposure resulted in increased levels of lipid peroxida-
tion products, as shown by the generation of 4-HNE
and MDA in lungs of ApoE-/- mice. It is possible that
CS augments the generation of lipid peroxidation
derived 4-HNE which would activate inflammatory sig-
naling pathways in the lungs of ApoE-/- mice, thereby
leading to an increased inflammatory response and
development of premature emphysema in these mice.
Reduced FEV1 with airflow limitation is often asso-
ciated with atherosclerosis and other cardiovascular
morbidities [2-4]. Our data show increased airspace
enlargement/alveolar destruction with altered lung com-
pliance and resistance in air-exposed ApoE-/- mice,
which were further aggravated in response to acute CS
exposure. Since increased levels of MMPs, such as
MMP-9 and MMP-12, are potentially involved in alveo-
lar destruction associated with altered lung function, we
measured the levels and activities of MMPs in lungs of
ApoE-/- mice. ApoE-/- mice exposed to CS showed the
increased levels of MMP-9 and MMP-12 in the lung
compared to WT or control ApoE-/- mice. Furthermore,
the activities of MMP-9 and MMP-12 were increased in
lungs of CS-exposed ApoE-/- mice as compared to that
of WT mice. It is possible that increased macrophage
infiltration into the lungs in response to CS exposure
may lead to elevated MMPs which might be the cause
for airspace enlargement and lower lung function
observed in these mice. It is noteworthy to mention
here that ApoE-/- mice when fed with high cholesterol
diet show increased inflammatory cell recruitment with
enhanced MMP-9 activity [31,32]. Furthermore, over-
expression of MMP-9 in ApoE-/- mice resulted in an
increased smooth muscle cell infiltration (lesion matura-
tion) and increased plaque formation in mouse aorta
[32]. These findings suggest that CS-mediated induction
of MMPs not only leads to increased alveolar destruc-
tion, but is also associated with the atherosclerotic pla-
que formation in these mice as evidenced earlier [12,13].
It has been shown that eNOS regulates endothelial
function and several components of the atherogenic
process, such as vascular smooth muscle cell contrac-
tion, proliferation, platelet aggregation, and monocyte
adhesion [27,33-35]. Previously, it has been shown that
ApoE-/- mice have a deficiency of eNOS which is exhib-
ited with high levels of atherosclerotic lesion formation
[36,37]. In the present study, the eNOS level was mea-
sured in order to understand whether CS-mediated
emphysema in ApoE-/- mice was associated with
endothelial dysfunction. The basal abundance of eNOS
was significantly decreased in the lungs of ApoE-/- mice
compared to WT mice with further reduction in
ApoE-/- mice exposed to CS. These data are supported
by a previous study demonstrating the decreased eNOS
level in ApoE-/- mice exposed to ozone was associated
with increased vascular dysfunction, oxidative stress,
mitochondrial damage, and atherogenesis [38]. Further-
more, knockdown of eNOS in ApoE-/- mice showed
increased lesions area with peripheral coronary athero-
sclerosis with myocardial fibrosis compared with
ApoE-/- alone [37]. These observations implicate that a
reduction of eNOS leads to altered endothelial function
in lung microvasculature and/or vascular disruption as
well as atherogenesis.
Recently, we and others have shown that eNOS is
regulated by acetylation/deacetylation via SIRT1 deace-
tylase or calorie restriction [34,39,40]. Previous studies
have shown that CS causes reduction in SIRT1 levels/
activity by posttranslational modification such as alkyla-
tion/carbonylation, which was associated with increased
proinflammatory gene expression [23,24,41]. Further-
more, calorie/dietary restriction or overexpression of
SIRT1 in ApoE-/- mice exhibited an anti-atherosclerosis
effect by inhibiting oxidized low-density lipoprotein
(LDL)-induced apoptosis, upregulation of eNOS expres-
sion and improved endothelium-dependent vasorelaxa-
tion [42,43]. Interestingly, the SIRT1 level and activity
were significantly decreased in the lungs of ApoE-/-
mice with further reduction in response to CS.
Decreased SIRT1 levels and activity may lead to
increased acetylation and inactivation of eNOS in the
lungs of ApoE-/- mice exposed to CS culminating
endothelial dysfunction. However, further studies are
required to study how post-translational modifications
(e.g. phospho-acetylation) affect its activity in response
to CS exposure. This may be one of the reasons that
ApoE-/- mice show signs of early aging [11] as SIRT1 is
an anti-aging protein [24]. Hence, SIRT1 activation (and
NAD+ replenishment) may not only activate eNOS
but will also inhibit endothelial cell senescence,
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atherosclerosis and inflammatory response in the lung
[23,44,45]. This is further validated by SIRT1 activation
or calorie restriction in ApoE-/- mice leads to protection
against atherosclerosis progression by upregulating
eNOS [43-45]. Interestingly, our preliminary data
showed that overexpression of SIRT1 in ApoE-/- mice in
double transgenic mice protected, whereas knockdown
of SIRT1 in ApoE-/- mice aggravated the lung phenotype
(inflammation and emphysema).
In summary, our study shows the augmented inflam-
matory response, increased oxidative stress, and airspace
enlargement with altered mechanical properties in lungs
of ApoE-/- mice in response to CS, which was associated
with increased MMPs, reduced SIRT1 activity and
eNOS levels. These mice have an accumulation of
excess lipids laden in blood and pulmonary arteries/lung
microvasculature which can undergo rapid oxidation by
CS-derived free radicals and oxidants leading to the gen-
eration of secondary oxidized lipid mediators/peroxida-
tion products/signaling molecules both systemically and
locally. This will trigger alterations in SIRT1, eNOS and
abnormal inflammatory responses leading to pulmonary
functional and morphological phenotype. This may be
one of the mechanisms linking CS-mediated accelerated
decline in lung function and aging in comorbidities of
cardiopulmonary diseases [46].
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